0001692415 2026-10-09 2026-10-09 true 0001692415 8-K/A 2026-10-09 Co-Diagnostics, Inc. UT 001-38148 46-2609363 2401 S. Foothill Drive Suite D Salt Lake City UT 84109 (801) 438-1036 false false false false Common Stock, $0.001 par value per share CODX NASDAQ false This Amendment No. 1 on Form 8-K/A amends the Current Report on Form 8-K filed by Co-Diagnostics, Inc. (the “Company”) on October 13, 2026 (the “Original Form 8-K”). This Amendment is being filed to (i) file a revised version of the ATM Waterfall Distribution Agreement as Exhibit 10.4, which reflects the removal of Maxim Group LLC (“Maxim”) as a party thereto, (ii) file as Exhibit 10.7 the ATM Payment Direction Letter between the Company and Maxim, pursuant to which Maxim agreed to remit net proceeds from sales under the Company’s at-the-market offering program to the deposit account specified therein, and (iii) amend and restate Item 1.01 to reflect such exhibits. Except as expressly set forth herein, this Amendment does not amend, update or restate any other information in the Original Form 8-K.